BIOINTRON Trademark

Trademark Overview


On Friday, March 31, 2023, a trademark application was filed for BIOINTRON with the United States Patent and Trademark Office. The USPTO has given the BIOINTRON trademark a serial number of 97868121. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, May 14, 2024. This trademark is owned by Biointron Biological Inc.. The BIOINTRON trademark is filed in the Pharmaceutical Products category with the following description:

Amino acids for medical purposes; Biological preparations for the treatment of cancer; Chemical reagents for medical or veterinary purposes; Diagnostic preparations for medical purposes; Enzyme preparations for medical purposes; Protein dietary supplements; Reagents and media for medical and veterinary diagnostic purposes; Reagents for medical use; Stem cells for medical purposes

General Information


Serial Number97868121
Word MarkBIOINTRON
Filing DateFriday, March 31, 2023
Status688 - NOTICE OF ALLOWANCE - ISSUED
Status DateTuesday, May 14, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, March 19, 2024

Trademark Statements


Description of MarkThe mark consists of stylized letters BIOINTRON with a design of curved intersecting lines to the left.
Goods and ServicesAmino acids for medical purposes; Biological preparations for the treatment of cancer; Chemical reagents for medical or veterinary purposes; Diagnostic preparations for medical purposes; Enzyme preparations for medical purposes; Protein dietary supplements; Reagents and media for medical and veterinary diagnostic purposes; Reagents for medical use; Stem cells for medical purposes
Indication of Colors claimedColor is not claimed as a feature of the mark.

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, April 25, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameBiointron Biological Inc.
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSHANGHAI PudongNew
CN

Party NameBiointron Biological Inc.
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSHANGHAI PudongNew
CN

Trademark Events


Event DateEvent Description
Tuesday, April 4, 2023NEW APPLICATION ENTERED
Tuesday, April 25, 2023NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, April 26, 2023NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, December 27, 2023ASSIGNED TO EXAMINER
Wednesday, December 27, 2023NON-FINAL ACTION WRITTEN
Wednesday, December 27, 2023NON-FINAL ACTION E-MAILED
Wednesday, December 27, 2023NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, January 29, 2024TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, January 29, 2024CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, January 30, 2024TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 8, 2024APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, February 28, 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, February 28, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 19, 2024PUBLISHED FOR OPPOSITION
Tuesday, March 19, 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 14, 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, November 14, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, November 14, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, November 14, 2024TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Thursday, November 14, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, November 14, 2024TEAS STATEMENT OF USE RECEIVED